These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33653498)

  • 1. Ultrasound-Induced Microbubble Cavitation Combined with miR-34a-Loaded Nanoparticles for the Treatment of Castration-Resistant Prostate Cancer.
    Wang Z; Chen C; Tao Y; Zou P; Gao F; Jia C; Liu L; Li G; Zhang G; Duan Y; Shi Q
    J Biomed Nanotechnol; 2021 Jan; 17(1):78-89. PubMed ID: 33653498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JMJD2A participates in cytoskeletal remodeling to regulate castration-resistant prostate cancer docetaxel resistance.
    Cai X; Duan X; Tang T; Cui S; Wu T
    BMC Cancer; 2023 May; 23(1):423. PubMed ID: 37165308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
    You B; Zhang KC
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
    Wang TY; Choe JW; Pu K; Devulapally R; Bachawal S; Machtaler S; Chowdhury SM; Luong R; Tian L; Khuri-Yakub B; Rao J; Paulmurugan R; Willmann JK
    J Control Release; 2015 Apr; 203():99-108. PubMed ID: 25687306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy.
    Gaur S; Wen Y; Song JH; Parikh NU; Mangala LS; Blessing AM; Ivan C; Wu SY; Varkaris A; Shi Y; Lopez-Berestein G; Frigo DE; Sood AK; Gallick GE
    Oncotarget; 2015 Oct; 6(30):29161-77. PubMed ID: 26313360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-23b and microRNA-27b plus flutamide treatment enhances apoptosis rate and decreases CCNG1 expression in a castration-resistant prostate cancer cell line.
    Pimenta RC; Viana NI; Amaral GQ; Park R; Morais DR; Pontes J; Guimaraes VR; Camargo JA; Leite KR; Nahas WC; Srougi M; Reis ST
    Tumour Biol; 2018 Nov; 40(11):1010428318803011. PubMed ID: 30400755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.
    Fu W; Hong Z; You X; Din J; Chen B; Zhao B; Yuan G; Li Q
    Biomed Pharmacother; 2019 Oct; 118():109374. PubMed ID: 31545228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L; Shi Q; Zheng K; Shen M; Ma J; Li F; Liu Y; Lin L; Tu W; Duan Y; Du L
    Theranostics; 2016; 6(10):1573-87. PubMed ID: 27446491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence.
    Jiao L; Deng Z; Xu C; Yu Y; Li Y; Yang C; Chen J; Liu Z; Huang G; Li LC; Sun Y
    J Cell Physiol; 2014 Jul; 229(7):834-44. PubMed ID: 24243035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
    Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
    Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-19a regulates proliferation and apoptosis of castration-resistant prostate cancer cells by targeting BTG1.
    Lu K; Liu C; Tao T; Zhang X; Zhang L; Sun C; Wang Y; Chen S; Xu B; Chen M
    FEBS Lett; 2015 Jun; 589(13):1485-90. PubMed ID: 25936765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
    Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
    Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
    Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
    Guan H; You Z; Wang C; Fang F; Peng R; Mao L; Xu B; Chen M
    Cancer Med; 2019 Apr; 8(4):1474-1485. PubMed ID: 30784214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
    Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
    J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer.
    Lin HM; Nikolic I; Yang J; Castillo L; Deng N; Chan CL; Yeung NK; Dodson E; Elsworth B; Spielman C; Lee BY; Boyer Z; Simpson KJ; Daly RJ; Horvath LG; Swarbrick A
    Sci Rep; 2018 May; 8(1):7820. PubMed ID: 29777112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network.
    Zhu J; Wang S; Zhang W; Qiu J; Shan Y; Yang D; Shen B
    Oncotarget; 2015 Dec; 6(41):43819-30. PubMed ID: 26540468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.